#$%^&*AU2013202117A120130502.pdf#####H:\ ar\IntenyvoverNRPoribl CC\AAR\50)2772 1_ DOC-2/03,2013 ABSTRACT The present invention relates to antisense antiviral compounds and methods of their use and production in inhibition of growth of viruses of the Orthomyxoviridae family and in the treatment of a viral infection. The compounds are particularly useful in the treatment of influenza virus infection in a mammal. Exemplary antisense antiviral compounds are substantially uncharged, or partially positively charged, morpholino oligonucleotides having: (1) a nuclease resistant backbone (2) 12-40 nucleotide bases and (3) a targeting sequence of at least 12 bases in length that hybridizes to a target region selected from the follow: (a) the 5 or 3 terminal 25 bases of the negative sense viral RNA segment of Influenzavirus A, Influenzavirus B and Influenzavirus C (b) the terminal 30 bases of the 5 or 3 terminus of the positive sense vcRNA (c) the 45 bases surrounding the AUG start codon of an influenza viral mRNA and (d) 50 bases surrounding the splice donor or acceptor sites of influenza mRNAs subject to alternative splicing. 104b
